A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor
about
Model structure of human APOBEC3GNatural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivityAncient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3GSpecies-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2Restriction of foamy viruses by APOBEC cytidine deaminasesGenetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivoMutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificitiesPlunder and stowaways: incorporation of cellular proteins by enveloped virusesDifferential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cellsRole and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsDifferential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.HIV-1 Vif and APOBEC3G: multiple roads to one goalA second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteinsHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHIV-1 Vif, APOBEC, and intrinsic immunityThe range of human APOBEC3H sensitivity to lentiviral Vif proteinsA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityIdentification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyIdentification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidationAll APOBEC3 family proteins differentially inhibit LINE-1 retrotranspositionProduction of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cellsIntracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.Analysis of the Macaca mulatta transcriptome and the sequence divergence between Macaca and humanMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allSuppression of APOBEC3-mediated restriction of HIV-1 by VifTarget cell APOBEC3C can induce limited G-to-A mutation in HIV-1RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapyMouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1)A naturally occurring bovine APOBEC3 confers resistance to bovine lentiviruses: implication for the co-evolution of bovids and their lentivirusesTwo-stepping through time: mammals and virusesIntrinsic antiviral immunityHIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesisAPOBEC3G: an intracellular centurionA challenge to the ancient origin of SIVagm based on African green monkey mitochondrial genomesMultiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.SIV replication in human cellsTwo regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.Going wild: lessons from naturally occurring T-lymphotropic lentiviruses
P2860
Q21092257-B03A8932-B344-48A0-9814-6EE9E1725AA9Q21144862-7533A2FF-55F5-43F1-86D4-E1C65E92E5C9Q21146408-49005636-4CD4-4D9F-9847-0B1013CFAD10Q21559418-247A6345-E38C-4D12-A8A3-436FB0F1C73BQ24299944-C433C9FE-114C-45B6-B4FC-4BACD9508013Q24305160-2CF89791-AB1B-4858-8A20-1C5A0D3AEF45Q24521469-FA14FA83-2611-4B5B-92E1-BF9F4B63E75FQ24524170-9A4C2738-C3A6-40E0-B206-0191D48248E0Q24529150-12C2FADB-8944-4902-8085-3D2309EBE46CQ24536003-0C9A2975-B70C-4C87-921F-CADDD16FF11AQ24537623-7AED6B00-7E40-43BD-A58F-F85D8189913BQ24544264-0E5DCE2D-348E-422D-B0D8-4B9CBFEB9CE9Q24564072-8D2C5EC9-D2E8-4129-BCE4-4481FD7E792CQ24564187-85B4AC45-87D6-48BB-85B1-84A109DF5D22Q24619114-36492F06-B903-44A0-B43A-3C6F221F1CF4Q24647833-4A2AC1B6-16D8-4DAB-A28E-014AF64E4137Q24653931-DE15B2BE-9196-44B8-9CB4-BDE4C67410BBQ24656551-EFA837F0-2343-45C9-A8DB-A33148D00AA4Q24670173-1D12828F-1CAD-4136-BCDF-628EE5F240D1Q24672209-0247F8BE-5C97-4CA2-800C-B97E469CFE36Q24675735-1FA0F275-4533-4C37-9988-15939C6052D8Q24796626-E1AB4741-CF44-49F2-A45A-B858659DAF0CQ24805644-F6EC19C3-B174-4DA7-89DF-3C371BF2E8C9Q24812692-C5D435AF-A3B6-4319-A7F7-40C8C25F6BDAQ26823568-06DC4A2A-C66D-49DB-9FAE-88988E6E7CFDQ27025150-A578BE6F-5A28-4CD7-8764-934875C6ED3EQ28469342-7ADDA815-B456-4527-9832-05A569F7D97FQ28474904-6933386D-A890-45F2-927F-098E8D045737Q28480578-A5BA9E63-FC20-48B0-BEF5-62C4B467B975Q28510924-4E7BF64C-4186-47AB-AC09-475FBF57225EQ28598363-BB659897-880B-47FD-BF88-C03E521E802EQ28709092-0C09449C-0A81-4035-BDF2-58859D3C383BQ28709929-5E0933CE-935B-4082-BB25-95367ACD0FB8Q28751706-F6BA7DB2-CE7F-4E77-94BE-6D17460BBD43Q28754989-24FEDC86-679C-4392-B1C8-36D83D659684Q28757478-D32A015B-8462-403A-B4C7-14454AC9C76AQ30381745-4C5C7833-CBDA-4917-8E0E-ACF686CD2DBCQ30417737-84B89E1E-2423-4BED-9A50-CAEDBDEA0492Q30483676-3EAD8CF7-F1DD-4677-A94A-5F0B4ABE1461Q31066870-5648A186-A005-44CC-B041-B3B635BDA0E5
P2860
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A single amino acid difference ...... pe 1 virion infectivity factor
@en
A single amino acid difference ...... e 1 virion infectivity factor.
@nl
type
label
A single amino acid difference ...... pe 1 virion infectivity factor
@en
A single amino acid difference ...... e 1 virion infectivity factor.
@nl
prefLabel
A single amino acid difference ...... pe 1 virion infectivity factor
@en
A single amino acid difference ...... e 1 virion infectivity factor.
@nl
P2093
P2860
P356
P1476
A single amino acid difference ...... pe 1 virion infectivity factor
@en
P2093
Brian P Doehle
Bryan R Cullen
Hal P Bogerd
Heather L Wiegand
P2860
P304
P356
10.1073/PNAS.0307713101
P407
P577
2004-03-03T00:00:00Z